Pulmuone Corporate

Pulmuone Corporate

KKRX:017810
8,290.00
KRW
-130.00
(-1.54%)
975.22EPS
7.69P/E
336.47BMarket Cap
Nov 18Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
41,167.56
45,149.66
49,581.44
54,527.05
58,954.83
5,709.11
63,946.6
56,643.27
68,422.43
124,352.05
39,113.68
57,823.91
91,649.06
94,637.07
Basic EPS, GAAP
-170.4
1,480.4
545.6
499.3
1,033.9
54.9
93.75
399
362.84
-815
255
637
490.61
1,186.04
Free Cash Flow per Basic Share
1,317.12
863.67
966.9
-419.46
-1,277.24
-97.24
-1,144.71
-1,125.55
-2,844.57
-2,417.73
864.43
1,335.26
251.64
1,370.15
Dividend per Share
144.95
143.07
142.3
128.85
128.85
13.3
158.66
127.41
359.46
794.1
216.68
342.16
637.39
640.75
Book Value per Share
5,697.48
7,016.73
7,776.23
6,986.19
7,192.02
8,985.88
10,606.86
12,021.94
12,634.2
11,156.74
8,582.73
8,182.2
8,350.74
9,100.39
Tangible Book Value per Share
5,049.92
6,352.7
7,143.21
5,665.81
5,652.84
7,482.85
9,151.53
10,729.44
9,838.48
8,497.94
5,998.77
4,847.94
5,105.36
5,878.11
Basic Weighted Avg Shares
37
37
37
37
37
398
37
41
37
23
77
56
37
37
Sales/Revenue/Turnover
1,521,708
1,678,094
1,846,488
2,030,673
2,195,658
2,271,973
2,381,451
2,311,200
2,518,896
2,838,304
2,993,468
3,213,697
3,380,189
3,491,489
Operating Margin (%)
3.05
3.17
2.14
1.87
2.4
1.77
1.28
1.99
1.53
0.93
2.07
2.86
2.76
3.04
Depreciation Expense
51,667
55,528
58,390
62,972
68,371
72,685
110,760
121,145
128,403
138,040
147,977
160,791
171,907
172,432
Net Income, GAAP
-6,299
55,023
20,319
18,595
38,506
21,848
3,492
16,280
13,357
-18,602
19,516
35,403
18,095
43,757
Effective Tax Rate (%)
748.52
36.56
60.87
65.47
41.18
55.16
209.42
34.09
97.75
- -
6.67
16.07
50.79
24.32
Profit Margin (%)
-0.41
3.28
1.1
0.92
1.75
0.96
0.15
0.7
0.53
-0.66
0.65
1.1
0.54
1.25
Working Capital
24,515
21,960
-39,551
-87,839
-117,671
-54,746
-153,349
-146,450
-92,846
-140,324
-247,665
-326,938
-309,067
-372,242
LT Debt
232,214
177,986
146,733
160,014
159,591
172,263
349,279
345,259
491,385
539,177
645,639
547,493
581,763
507,832
Total Equity
272,319
334,693
330,353
366,237
375,830
445,686
463,102
512,939
589,791
546,647
506,545
583,439
617,725
626,836
Return on Invested Capital (%)
-39.25
4.55
2.16
1.87
4.2
2.23
-3.38
2.48
0.06
- -
3.51
4.38
2.49
4.41
Return on Capital (%)
-20.79
9.93
4.81
4.51
7.34
4.88
-1.39
3.19
1.91
- -
4.75
5.23
2.82
5.03
Return on Common Equity (%)
-2.87
23.19
7.38
6.76
14.59
7.25
0.96
3.86
2.93
-4.25
5.38
11.47
5.94
14.61

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
665,406
674,549
720,657
LT Borrowings
206,507
208,622
142,762
LT Finance Leases
375,256
371,005
365,070
Preferred Equity and Hybrid Capital
2,017
2,017
2,017
Shares Outstanding
37
37
37
Market Capitalization
477,399
427,962
336,467

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
798,418
833,023
796,254
Cash, Cash Equivalents & STI
255,446
217,702
164,540
Accounts Receivable, Net
303,382
340,007
350,868
Inventories
188,518
210,054
209,668
Total Current Liabilities
1,107,484
1,144,406
1,168,496
Payables & Accruals
- -
- -
- -
ST Debt
665,406
674,549
720,657
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.81%
4.28%
5.88%
Free Cash Flow
-15.41%
-42.9%
-87.49%
Net Income, GAAP
-9.2%
-85.92%
-48.89%
Sales/Revenue/Turnover
6.31%
7.94%
5.18%
Total Cash Common Dividend
- -
44.26%
23.62%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
769,292
793,049
833,657
817,698
3,213,697
2025
793,491
839,113
888,395
859,190
3,380,189
2026
850,353
893,551
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2
49
295
373.61
637
2025
-47.66
-284
590.97
130.96
490.61
2026
176.41
287.69
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.43
77.26
92.87
110.08
342.16
2025
126.84
386.7
120.06
140.05
637.39
2026
137.34
243.3
- -
- -
- -

Company Description

CEO
Wu-Bong Lee
Full Time Employees
546
Sector
Consumer non-durables
Industry
Food: specialty/candy
Address
730-27 Samyang-ro Eumseong-gun NC South Korea
IPO Date
Oct 5, 1995
Business
Pulmuone Co., Ltd. Pulmuone Co., Ltd. (KRX: 017810) is a South Korean holding company specializing in wholesome, plant-based, and LOHAS (lifestyle of health and sustainability) foods, beverages, and related services. Founded in 1981 as an organic produce farm shop in Seoul, the company is headquartered in Eumseong County, Chungcheongbuk-do, South Korea, and operates through key subsidiaries including Pulmuone Foods Co., Ltd., which leads in fresh foods production; Foodmerce Co., Ltd., focused on food service distribution; Pulmuone Food&Culture Co., Ltd., providing concessions, dine-out brands such as Nature Is Delicious, CHAN:JANG, and Smart Kitchen, and facility management; Pulmuone Health & Living Co., Ltd., offering health supplements, green vegetable juice, probiotics, home meal replacements, baby food, skincare, pet food, and LOHAS kitchen products; ORGA Whole Foods Inc., a fresh market chain with over 5,000 eco-friendly items; Pulmuone Waters Co., Ltd., producing premium bottled water; Pulmuone Danone Co., Ltd., manufacturing yogurt brands like Activia and Danone Greek; and logistics arm Exofresh Logistics Co., Ltd., supported by 19 low-temperature centers. Core products encompass tofu (market leader in Korea and a global top producer), bean sprouts, eggs, fresh noodles, fresh-squeezed juice, ready-to-eat home meal replacements, kimchi, natto, mineral water, fermented milk, and innovative items like fresh ramen; these are manufactured across 14 advanced plants in South Korea, including the world's largest tofu facility in Eumseong producing 280,000 squares daily, with stringent cold-chain logistics ensuring freshness nationwide and internationally. The company serves retail, foodservice, institutional, and direct-to-consumer markets in South Korea, the United States via Pulmuone USA, Inc. (with plants in California, Massachusetts, and more, holding top tofu and kimchi shares), Japan through Asahico Co., Ltd. (tofu and meat alternatives), and China via Pumeiduo entities (noodles, kimchi, health products), emphasizing eco-friendly, low-carbon, and animal welfare standards. Recent developments include plans to expand tofu production into Europe with a new subsidiary launching early 2025, enhancing plant upgrades for global reach; a strategic partnership and investment with BlueNalu Inc. for cell-based seafood introduction to South Korea; and a 2024 collaboration with Germany's Infinite Roots to develop innovative, locally tailored protein products using mycelium technology, underscoring Pulmuone's push into sustainable alternative proteins.